Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 31, 1999

View Archived Issues

Ortec requests FDA permission to initiate CCS trial for diabetic ulcer therapy

Company Profile: Verne Mendel Medical

Apligraf skin construct speeds healing of diabetic foot ulcers

Topical foscarnet for aciclovir-unresponsive HSV lesions in AIDS patients

SciClone licenses new class of immunomodulators from University of California

Searle pays milestone to Epimmune for anticancer candidate

Glaxo Wellcome proposes to discontinue Wellferon

Interneuron completes patient enrollment in ECCO 2000

Muse approved in Spain

Diatide awarded patent covering somatostatin analogues for tumor diagnosis and therapy

Boston Life Sciences reviews progress for first half of 1999

NDA for subcutaneous Repronex approved by FDA

New IGT compound shows promise in stroke therapy

AstraZeneca terminates two development agreements during first half of 1999

Preclinical and mechanism of action studies support efficacy of the NHE-1 inhibitor cariporide

Anti-RSV agents reported in patent literature by ViroPharma

Novel emopamil binding site inhibitors synthesized and evaluated at AstraZeneca

Novel BK channel modulators for stroke reported by Bristol-Myers Squibb

AHP investigates oxazole derivatives with potential in treating various CNS disorders

HRT may slow periodontal disease progression

Celecoxib NDA receives priority review designation for FAP

ME-3230, an orally active prodrug of a potent gpIIb/IIIa antagonist

FDA requests modifications to Bexxar BLA

ETA antagonist TA-0201 protects against deleterious effects of MI in dogs

New treatment for urinary incontinence in the Recordati pipeline

DuPont team presents new cdk inhibitors at ACS meeting

5-ht6 receptor function under study at SmithKline Beecham

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...